IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2005;46:4804-4808.)
© 2005 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.05-0604

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hancock, H. A.
Right arrow Articles by Kraft, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hancock, H. A.
Right arrow Articles by Kraft, T. W.

Acute Aminoglycoside Retinal Toxicity In Vivo and In Vitro

Heather A. Hancock,1,2 Clyde Guidry,3 Russell W. Read,3,4 Edgar L. Ready,3 and Timothy W. Kraft5

1From the Departments of Medicine, 3Ophthalmology, 4Pathology, and 5Vision Sciences, University of Alabama, Birmingham, Alabama.

PURPOSE. Intentional and inadvertent intraocular administration of aminoglycosides is associated with cases of retinal toxicity. Clinical manifestations resemble a vaso-occlusive event and include edema, intraretinal hemorrhage, and nonperfusion detected by fluorescein angiogram. This study was conducted to measure the retinal function in avascular and isolated perfused retinas to separate vascular and neurologic effects of gentamicin. Enhanced understanding of the mechanism of gentamicin toxicity may lead to development of aminoglycosides that can be used to treat ophthalmic infections without retinal damage.

METHODS. Whole animals and isolated rabbit and rat retina preparations were used to study the dose dependence and reversibility of toxicity on the ERG, with a 1- and a 10-mg/mL solution of gentamicin. The amplitude and implicit times of the a-, b-, and c-waves were measured before, during, and after exposure to the drug.

RESULTS. In whole-animal ERG studies, intraocular administration of gentamicin eliminated the b-wave but left the a-wave intact. The c-wave was reduced in amplitude. Histopathologic evaluation demonstrated diffuse disruption of the nerve fiber layer and the inner plexiform layers. Isolated retinal studies showed that the b-wave was reduced in amplitude in the presence of low-dose gentamicin (1 mg/mL) and completely eliminated by high-dose gentamicin (10 mg/mL). This effect was reversible for short-term exposure to gentamicin.

CONCLUSIONS. The results indicate that the initial loss of function due to exposure to aminoglycoside antibiotics is independent of the vascular supply. Elimination of the b-wave was dose dependent and reversible, indicating that a component of gentamicin toxicity is mediated through pathways other than vascular supply. Short-term effects are reversible, suggesting a receptor-mediated process.





This article has been cited by other articles:


Home page
Arch OphthalmolHome page
B. Dille
Toxicity of Intraocular Gentamicin
Arch Ophthalmol, October 1, 2007; 125(10): 1442 - 1442.
[Full Text] [PDF]


Home page
Arch OphthalmolHome page
M. Soheilian, N. Rafati, S. Yazdani, and for the Traumatic Endophthalmitis Trial (TET) Rese
Toxicity of Intraocular Gentamicin Reply
Arch Ophthalmol, October 1, 2007; 125(10): 1442 - 1443.
[Full Text] [PDF]


Home page
Arch OphthalmolHome page
D. Dierks, B. Lei, K. Zhang, and D. P. Hainsworth
Effects of Intravitreous Injection of Preserved and Nonpreserved Triamcinolone in Rabbit Retina--Reply
Arch Ophthalmol, November 1, 2006; 124(11): 1666 - 1668.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Association for Research in Vision and Ophthalmology